🇺🇸 FDA
Patent

US 7183272

Crystal forms of oxcarbazepine and processes for their preparation

granted A61PA61P25/08A61P25/16

Quick answer

US patent 7183272 (Crystal forms of oxcarbazepine and processes for their preparation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
68
CPC classes
A61P, A61P25/08, A61P25/16, A61P43/00